Aclarion (ACONW) Cash from Investing Activities (2021 - 2026)
Aclarion (ACONW) reported Cash from Investing Activities of -$49345.0 for Q1 2026, up 36.97% on a YoY basis from -$36026.2 in Q1 2025, and down 19.02% quarter-over-quarter from -$41461.0 in Q4 2025.
Aclarion (ACONW) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Aclarion has reported Cash from Investing Activities for 6 years, with the latest figure at -$49345.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 36.97% year-over-year to -$49345.0; the trailing twelve-month figure through Mar 2026 stood at -$174959.0 (up 48.02% YoY), and the FY2025 full-year result was -$203902.0, up 36.66% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$49345.0, down from -$41461.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$11719.0 in Q1 2023, with the low at -$103697.0 in Q3 2024.
- Historically, Cash from Investing Activities has averaged -$53092.7 across 5 years, with a median of -$48248.0 in 2022.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities surged 85.82% — and 2024, when it sank 699.58%.
- Aclarion's Cash from Investing Activities stood at -$48248.0 in 2022, then gained by 29.7% to -$33919.0 in 2023, then tumbled by 79.01% to -$60717.0 in 2024, then surged by 31.71% to -$41461.0 in 2025, then decreased by 19.02% to -$49345.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$49345.0 (Q1 2026), -$41461.0 (Q4 2025), and -$40151.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | -388.71 Mn |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | 747.39 Mn |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | -13.90 Mn |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | 48.08 Mn |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | 137.98 Mn |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | -1.31 Mn |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | -112.49 Mn |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | -26,000.00 |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | -15.87 Mn |
| 10 | Aclarion | - | - | 3,750.00 | -49,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49,345.00 |
| Mar 31, 2026 | -49,345.00 |
| Dec 31, 2025 | -41,461.00 |
| Dec 31, 2025 | -41,461.00 |
| Sep 30, 2025 | -40,151.00 |
| Sep 30, 2025 | -40,151.00 |
| Jun 30, 2025 | -44,002.00 |
| Jun 30, 2025 | -44,002.00 |
| Mar 31, 2025 | -78,288.00 |
| Mar 31, 2025 | -78,288.00 |
| Dec 31, 2024 | -60,717.00 |
| Dec 31, 2024 | -60,717.00 |
| Sep 30, 2024 | -103,697.00 |
| Sep 30, 2024 | -103,697.00 |
| Jun 30, 2024 | -93,866.00 |
| Jun 30, 2024 | -93,866.00 |
| Mar 31, 2024 | -63,657.00 |
| Mar 31, 2024 | -63,657.00 |
| Dec 31, 2023 | -33,919.00 |
| Dec 31, 2023 | -33,919.00 |